The JRO have issued guidance for CI’s for UCL and UCLH sponsored studies.
This guidance can be accessed here.
Written agreement from the sponsor will be required before the restart of all activity.
The “sponsor” at UCL and UCLH are represented by the following groups (only):
- >UCLH/UCL Joint Research Office (JRO)
- Cancer Clinical Trials Unit at UCL (CTC)
- Comprehensive Clinical Trials Unit at UCL (CCTU)
- PRIMENT at UCL
- MRC Clinical Trials Unit at UCL
Read our guidance and principles which should be followed to obtain the approval to re-start research sponsored by UCL or UCLH.